Ligand validation:8YB3

D0L: (2S)-2-[[(2S)-1-heptylpyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoic acid

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8YB3_D0L_A_502	89%	57%	0.06	0.937	0.59	1.06	-	1	0	0	100%	1
8YB3_D0L_B_502	81%	61%	0.066	0.916	0.62	0.87	-	2	0	0	100%	1
8YB0_D0L_B_502	98%	65%	0.042	0.963	0.58	0.76	-	-	0	0	100%	1
8YB2_D0L_B_502	97%	63%	0.044	0.958	0.63	0.77	-	-	0	0	100%	1
7D1F_D0L_B_502	95%	51%	0.065	0.968	0.82	1.07	-	3	0	0	100%	1
9KT5_D0L_A_504	94%	63%	0.07	0.97	0.56	0.85	-	1	0	0	100%	1
7WY1_D0L_B_502	93%	50%	0.065	0.959	0.72	1.18	-	3	0	0	100%	1
8YB1_D0L_A_502	91%	54%	0.056	0.94	0.58	1.17	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.